Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 03, 2026
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, shared clinical validation data for its OncodetectTM MRD test at the 2
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 11 abstracts at the American Society of Clinical Oncology
2 Healthcare Stocks to Buy Hand Over Fist in January
05:22am, Thursday, 16'th Jan 2025
Stocks tend to perform well in January, but that's not a good reason to invest this month. Strong returns aren't made in a single 30-day period.
Exact Sciences Sparks Analyst Optimism Amid Competitive Multi-Cancer Test Market
01:04pm, Monday, 13'th Jan 2025
On Sunday, Exact Sciences Corp EXAS reported preliminary fiscal year 2024 sales of $2.76 billion, up 10% year-over-year, compared to consensus of $2.74 billion.
Exact Sciences Announces Preliminary Fourth Quarter 2024 Results
07:00pm, Sunday, 12'th Jan 2025
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company expects to report revenue of $713 mil
Should Exact Sciences Stock Stay in Your Portfolio Right Now?
08:11am, Wednesday, 08'th Jan 2025
EXAS' solid focus on expanding its lead Cologuard test and advancing new solutions bodes well for investors.
Exact Sciences to Participate in J.P. Morgan Healthcare Conference
06:00am, Thursday, 02'nd Jan 2025
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the follow
AAPA Awarded Grant from Exact Sciences to Improve Colorectal Cancer Screening Rates
10:01am, Monday, 09'th Dec 2024
ALEXANDRIA, Va., Dec. 09, 2024 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA) is proud to announce a new project, made possible through a grant from Exact Sciences, that aims
Exact Sciences Corporation (EXAS) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
11:06am, Wednesday, 04'th Dec 2024
Exact Sciences Corporation (NASDAQ:EXAS ) Annual Evercore ISI HealthCONx Healthcare Conference December 4, 2024 7:30 AM ET Company Participants Kevin Conroy - CEO Aaron Bloomer - CFO Conference Call P
Exact Sciences Corporation (EXAS) Citi's 2024 Global Healthcare Conference (Transcript)
12:02pm, Tuesday, 03'rd Dec 2024
Exact Sciences Corporation (NASDAQ:EXAS ) Citi's 2024 Global Healthcare Conference December 3, 2024 8:45 AM ET Company Participants Kevin Conroy - Chairman and CEO Aaron Bloomer - EVP, Finance Confere
Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening
09:30am, Monday, 02'nd Dec 2024
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, has teamed up with multi-platinum, Grammy award-winning artist Lil Jon on the “Get
Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED)
01:24pm, Tuesday, 26'th Nov 2024
Editor's note: The headline of this story was updated to correct an error related to the reported day of the week.
Why Is Exact Sciences Stock Trading Higher On Monday?
12:21pm, Tuesday, 26'th Nov 2024
On Monday, the Centers for Medicare & Medicaid Services posted final payment determinations for its 2025 Clinical Laboratory Fee Schedule.
Exact Sciences to Participate in December Investor Conferences
06:00am, Tuesday, 26'th Nov 2024
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the follow
Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024
05:35pm, Monday, 25'th Nov 2024
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 10 abstracts demonstrating the breadth of its Precision O
